Shopping Cart
- Remove All
 
Your shopping cart is currently empty
[D-Ala2] Leu-Enkephalinamide, an enkephalin analog, exhibits significant corneal permeability and analgesic properties, making it suitable for ocular disease research [1] [2].
![[D-Ala2] Leu-Enkephalinamide](/group3/M00/03/3B/CgoaEGY7SvOEQvgvAAAAADyw490402.png)
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | |
| 100 mg | Inquiry | 3-6 months | 
| Description | [D-Ala2] Leu-Enkephalinamide, an enkephalin analog, exhibits significant corneal permeability and analgesic properties, making it suitable for ocular disease research [1] [2].  | 
| In vitro | [D-Ala2] Leu-Enkephalinamide (MEA) functions as an agonist at opioid receptors, selectively binding and modulating neurotransmitter release to produce analgesic effects. It mimics endogenous opioid peptides, primarily targeting mu-type receptors crucial for pain regulation in the central nervous system.  | 
| In vivo | D-Ala2-Leu-enkephalinamide administered subcutaneously (s.c.) demonstrates increased activity in morphine-dependent animals [2].  | 
| Molecular Weight | 568.66 | 
| Formula | C29H40N6O6 | 
| Cas No. | 65189-64-2 | 
| Sequence Short | Y-{d-Ala}-GFL-NH2 | 
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.